Tableaux LLC Boosts Holdings in CME Group Inc. $CME

Tableaux LLC lifted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 4,840.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 40,462 shares of the financial services provider’s stock after buying an additional 39,643 shares during the period. CME Group comprises 0.8% of Tableaux LLC’s portfolio, making the stock its 12th largest holding. Tableaux LLC’s holdings in CME Group were worth $11,152,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Webster Bank N. A. lifted its holdings in shares of CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after buying an additional 60 shares during the period. Highline Wealth Partners LLC boosted its position in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 43 shares during the period. Trifecta Capital Advisors LLC raised its holdings in CME Group by 59.2% during the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 42 shares during the period. Ransom Advisory Ltd bought a new position in CME Group in the 1st quarter worth approximately $31,000. Finally, Westside Investment Management Inc. grew its stake in CME Group by 105.0% during the second quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 63 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Performance

Shares of CME stock opened at $273.09 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1 year low of $224.62 and a 1 year high of $290.79. The firm has a market capitalization of $98.48 billion, a price-to-earnings ratio of 26.46, a price-to-earnings-growth ratio of 4.41 and a beta of 0.38. The business has a fifty day moving average of $268.74 and a 200 day moving average of $272.78.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.05. The company had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. CME Group’s quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.68 EPS. As a group, research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio (DPR) is 48.45%.

Insider Buying and Selling at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider directly owned 9,508 shares of the company’s stock, valued at $2,470,463.64. The trade was a 3.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the company’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the transaction, the director directly owned 1,091 shares of the company’s stock, valued at $287,511.23. The trade was a 47.82% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 14,043 shares of company stock worth $3,791,486. 0.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Jefferies Financial Group decreased their price objective on CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a report on Friday, October 10th. Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and increased their price target for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. The Goldman Sachs Group boosted their price objective on shares of CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a research report on Thursday, October 23rd. TD Cowen raised their price target on CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a research note on Thursday, October 23rd. Finally, Argus lowered their target price on CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Eight research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $287.65.

Check Out Our Latest Research Report on CME Group

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.